English
Back
Download
Log in to access Online Inquiry
Back to the Top

NEWS

Inhibikase Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sands Capital Life Sciences Pulse Fund II, L.P.(16.3%),Sands Capital Ventures, LLC(16.3%), etc.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
3534 Views
Comment
Sign in to post a comment